...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Additional Exempt Distribution
2
Oct 23, 2023 05:17PM

Part of the transaction includes 5 million share purchase warrants that can be exchanged for common shares before the exercise date as noted, at 82 cents (US).

 

Koo

Share
New Message
Please login to post a reply